PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDaunorubicin hydrochloride
Daunorubicin hydrochloride
Download report
Favorite
Drugs Approved for Childhood Cancers
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
459 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloid leukemia acuteD015470—C92.0638854412194
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.010322613984
LeukemiaD007938—C951235371583
Promyelocytic leukemia acuteD015473—C92.4—332—8
Philadelphia chromosomeD010677——1411—6
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelodysplastic syndromesD009190—D46112117—348
LymphomaD008223—C85.9—57——12
Myeloid leukemiaD007951—C92267——11
Monocytic leukemia acuteD007948——145——9
Myelomonocytic leukemia acuteD015479—C92.5145——9
Myelomonocytic leukemia chronicD015477—C93.1432——8
Megakaryoblastic leukemia acuteD007947—C94.2125——7
Erythroblastic leukemia acuteD004915EFO_1001257C94.0125——7
Breast neoplasmsD001943EFO_0003869C50421——6
SarcomaD012509——422——6
Show 33 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Large b-cell lymphoma diffuseD016403—C83.341———4
Non-hodgkin lymphomaD008228—C85.912———3
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340—22———3
Hodgkin diseaseD006689—C8121———3
Triple negative breast neoplasmsD064726——21———3
Urinary bladder neoplasmsD001749—C67—2———2
Primary myelofibrosisD055728—D47.421———2
Myeloid leukemia chronic-phaseD015466——11———2
Mantle-cell lymphomaD020522—C83.112———2
Renal cell carcinomaD002292EFO_0000376—11———2
Show 14 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hematologic neoplasmsD019337——4————4
Ovarian neoplasmsD010051EFO_0003893C563————3
Fallopian tube neoplasmsD005185——2————2
Burkitt lymphomaD002051—C83.72————2
Stomach neoplasmsD013274EFO_0003897C162————2
Prostatic neoplasmsD011471—C611————1
Castration-resistant prostatic neoplasmsD064129——1————1
Pancreatic neoplasmsD010190EFO_0003860C251————1
Multiple myelomaD009101—C90.01————1
B-cell chronic lymphocytic leukemiaD015451—C91.11————1
Show 16 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ataxia telangiectasiaD001260Orphanet_100G11.3————11
HivD006678—O98.7————11
CardiomyopathiesD009202EFO_0000318I42————11
InfertilityD007246HP_0000789—————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 263 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
666 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use